期刊
JOURNAL OF PSYCHOPHARMACOLOGY
卷 29, 期 3, 页码 241-253出版社
SAGE PUBLICATIONS LTD
DOI: 10.1177/0269881114568040
关键词
Hallucinogens; psychedelics; serotonin; psilocybin; ketamine; LSD; substance-assisted psychotherapy; psychedelic therapy; psycholytic therapy; obsessive-compulsive disorder; substance addiction
资金
- Research Training Group GRK 'Sensory Computation in Neural Systems' by the German Research Foundation (DFG) [1589/1]
Interest in the therapeutic potential of psychedelic substances has recently resumed. During an early phase of human psychedelic research, their therapeutic application in different pathologies had been suggested, and the first evidence for efficacy was provided. The range of recent clinical applications of psychedelics spans from cluster headaches and obsessive-compulsive disorder to addiction and the treatment of fear and anxiety in patients suffering from terminal illness, indicating potentially different therapeutic mechanisms. A variety of approaches in psychotherapy emphasize subjective experiences, such as so-called peak experiences or afterglow phenomena, as differentially mediating therapeutic action. This review aims to re-evaluate earlier and recent concepts of how psychedelic substances may exert beneficial effects. After a short outline of neurophenomenological aspects, we discuss different approaches to how psychedelics are used in psychotherapy. Finally, we summarize evidence for the relationship between subjective experiences and therapeutic success. While the distinction between pharmacological and psychological action obviously cannot be clearcut, they do appear to contribute differently from each other when their effects are compared with regard to pathologies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据